Iniciar sesión

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the reabsorption of these drugs can be hindered. When urine becomes alkaline, weak acidic drugs become predominantly ionized. Due to the decreased permeability of ionized forms through tubular cells, these drugs remain in the lumen and are ultimately expelled in the urine. This mechanism, known as 'ion trapping,' prevents reabsorption and enhances renal clearance of unwanted drugs. For example, in cases of phenobarbital overdose—a weak acid—treatment with bicarbonate is used to alkalinize the urine. This action ionizes the drug, impeding its back diffusion. Similarly, when dealing with an overdose of weakly basic drugs such as amphetamines, urine acidification is employed to ensure the ionized drug is not reabsorbed.

Tags
Renal ExcretionTubular ReabsorptionGlomerular FiltrateDistal Convoluted TubuleLipophilic DrugsPassive ReabsorptionDrug IonizationUrine PHIon TrappingRenal ClearancePhenobarbital OverdoseBicarbonate TreatmentUrine AcidificationWeak AcidsWeak Bases

Del capítulo 3:

article

Now Playing

3.20 : Drug Elimination by Renal Route: Tubular Reabsorption

Pharmacokinetics

2.9K Vistas

article

3.1 : Farmacocinética: Introducción

Pharmacokinetics

4.7K Vistas

article

3.2 : Mecanismo de absorción de fármacos: transporte pasivo de membrana

Pharmacokinetics

3.2K Vistas

article

3.3 : Mecanismo de absorción de fármacos: transporte de membrana mediado por portadores

Pharmacokinetics

3.2K Vistas

article

3.4 : Absorción de fármacos: factores que afectan a la absorción gastrointestinal

Pharmacokinetics

3.4K Vistas

article

3.5 : Biodisponibilidad: Visión general

Pharmacokinetics

2.3K Vistas

article

3.6 : Factores que influyen en la biodisponibilidad: eliminación en el primer paso

Pharmacokinetics

5.7K Vistas

article

3.7 : Bioequivalencia: Visión general

Pharmacokinetics

849 Vistas

article

3.8 : Efecto de primer paso

Pharmacokinetics

4.7K Vistas

article

3.9 : Curso temporal del efecto de la droga

Pharmacokinetics

1.8K Vistas

article

3.10 : Distribución de fármacos: unión de tejidos

Pharmacokinetics

2.3K Vistas

article

3.11 : Barreras fisiológicas

Pharmacokinetics

3.2K Vistas

article

3.12 : Distribución de fármacos: unión a proteínas plasmáticas

Pharmacokinetics

3.9K Vistas

article

3.13 : Modelos de compartimentos: Modelo de un solo compartimento

Pharmacokinetics

1.9K Vistas

article

3.14 : Modelos de compartimentos: modelo de dos compartimentos

Pharmacokinetics

4.8K Vistas

See More

JoVE Logo

Privacidad

Condiciones de uso

Políticas

Investigación

Educación

ACERCA DE JoVE

Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados